iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Coagulopathy (Acquired)

Coagulopathy (Acquired)

Management of acquired clotting disorders.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyCritical Care

Clinical Guidelines

Diagnosis and management of acquired coagulation inhibitors: a joint UKHCDO and BCSH guideline
National
Reducing the Risk of Venous Thromboembolism during Pregnancy
National
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Local
ACOG Practice Bulletin No. 183: Postpartum Hemorrhage
Local
NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesĀ®): Wilms Tumor (Nephroblastoma), Version 2.2021
Local

Recent iatroX Q&As

  • What initial investigations should I perform for a patient presenting with unexplained bleeding and suspected acquired coagulopathy?Updated: 8/22/2025
  • What are the recommended management strategies for a patient with acquired coagulopathy due to anticoagulant therapy?Updated: 8/22/2025
  • What lifestyle modifications should I advise patients with acquired coagulopathy to minimize bleeding risks?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play